story of the week
Tumor-Infiltrating Lymphocyte Therapy vs Ipilimumab for Advanced Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
N. Engl. J. Med 2022 Dec 08;387(23)2113-2125, MW Rohaan, TH Borch, JH van den Berg, Ö Met, R Kessels, MH Geukes Foppen, J Stoltenborg Granhøj, B Nuijen, C Nijenhuis, I Jedema, M van Zon, S Scheij, JH Beijnen, M Hansen, C Voermans, IM Noringriis, TJ Monberg, RB Holmstroem, LDV Wever, M van Dijk, LG Grijpink-Ongering, LHM Valkenet, A Torres Acosta, M Karger, JSW Borgers, RMT Ten Ham, VP Retèl, WH van Harten, F Lalezari, H van Tinteren, AAM van der Veldt, GAP Hospers, MAM Stevense-den Boer, KPM Suijkerbuijk, MJB Aarts, D Piersma, AJM van den Eertwegh, JB de Groot, G Vreugdenhil, E Kapiteijn, MJ Boers-Sonderen, WE Fiets, FWPJ van den Berkmortel, E Ellebaek, LR Hölmich, ACJ van Akkooi, WJ van Houdt, MWJM Wouters, JV van Thienen, CU Blank, A Meerveld-Eggink, S Klobuch, S Wilgenhof, TN Schumacher, M Donia, IM Svane, JBAG HaanenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.